Insiders · Profile

CHESS ROBERT

Director at Twist Bioscience · Director at NEKTAR THERAPEUTICS. Filing since 8 Jan 2007. CIK 0001227886

Company
Date
Role
Action
Shares
Amount
Of holding
7 Aug 2026
Director
Sold on a plan
18,417
$2.04M
46.6%
17 Mar 2026
Director
Sold on a plan
10,000
$470.00K
32.2%
13 Feb 2026
Director
Sold at will
2,184
$105.40K
9.4%
7 Feb 2025
Director
Sold at will
2,940
$156.22K
13.9%
7 Jan 2025
Director
Sold on a plan
5,000
$250.00K
23.1%
5 Dec 2024
Director
Sold on a plan
3,504
$181.70K
13.9%
11 Nov 2024
Director
Sold on a plan
3,600
$170.14K
14.3%
14 Jun 2024
Director
Sold on a plan
19,500
$23.40K
7.1%
8 Feb 2024
Director
Sold at will
4,110
$143.78K
6.0%
22 Sep 2022
Director
Sold on a plan
15,300
$23.10K
6.3%
4 Feb 2022
Director
Sold, plan not stated
253
$14.90K
0.5%
1 Nov 2021
Director
Sold, plan not stated
4,000
$480.61K
7.3%
21 Oct 2021
Director
Sold, plan not stated
3,700
$444.54K
6.3%
19 Oct 2021
Director
Sold, plan not stated
300
$36.00K
0.5%
22 Sep 2021
Director
Sold, plan not stated
4,600
$82.52K
1.6%
10 Sep 2021
Director
Sold, plan not stated
4,000
$480.91K
6.3%
9 Sep 2021
Director
Sold, plan not stated
10,279
$164.67K
3.6%
8 Sep 2021
Director
Sold, plan not stated
8,000
$128.00K
2.8%
22 Jul 2021
Director
Sold, plan not stated
91
$1.53K
0.0%
21 Jul 2021
Director
Sold, plan not stated
3,524
$59.24K
1.2%
20 Jul 2021
Director
Sold, plan not stated
2,106
$35.38K
0.7%
12 Jul 2021
Director
Sold, plan not stated
4,000
$503.65K
6.0%
23 Jun 2021
Director
Sold, plan not stated
4,000
$480.41K
5.6%
12 May 2021
Director
Sold, plan not stated
8,000
$154.72K
2.8%
14 Apr 2021
Director
Sold, plan not stated
8,000
$151.84K
2.8%
5 Feb 2021
Director
Sold, plan not stated
706
$112.64K
1.0%
25 Sep 2020
Director
Sold, plan not stated
5,500
$97.63K
1.9%
8 Sep 2020
Director
Sold, plan not stated
8,000
$148.24K
2.8%
8 Jul 2020
Director
Sold, plan not stated
8,000
$196.64K
2.8%
15 Apr 2020
Director
Sold, plan not stated
8,000
$147.01K
2.8%
11 Mar 2020
Director
Sold, plan not stated
8,000
$134.32K
2.8%
12 Feb 2020
Director
Sold, plan not stated
8,000
$188.00K
2.8%
27 Sep 2019
Director
Sold, plan not stated
4,000
$71.96K
1.4%
19 Sep 2018
Director
Sold, plan not stated
4,500
$255.65K
1.6%
5 Jun 2018
Director
Sold, plan not stated
10,000
$551.60K
3.5%
3 May 2018
Director
Sold, plan not stated
25,000
$2.07M
8.4%
6 Apr 2018
Director
Sold, plan not stated
25,000
$2.30M
8.4%
21 Sep 2017
Director
Sold, plan not stated
6,400
$139.01K
2.3%
15 May 2017
Director
Sold, plan not stated
5,000
$98.95K
1.8%
17 Apr 2017
Director
Sold, plan not stated
5,000
$93.60K
1.8%
14 Mar 2017
Director
Sold, plan not stated
5,000
$77.05K
1.8%
15 Sep 2016
Director
Sold, plan not stated
12,000
$230.52K
4.6%
1 Aug 2016
Director
Sold, plan not stated
5,000
$86.30K
1.9%
1 Jul 2016
Director
Sold, plan not stated
5,000
$70.50K
1.9%
1 Jun 2016
Director
Sold, plan not stated
5,000
$77.50K
1.9%
19 Jun 2015
Director
Sold, plan not stated
15,000
$177.15K
5.4%
29 Dec 2014
Director
Sold, plan not stated
29,500
$452.53K
10.2%
13 Jul 2012
Director
Sold, plan not stated
24,001
$204.01K
8.4%
8 Mar 2011
Director
Sold, plan not stated
4,500
$40.50K
1.7%
10 May 2010
Director
Sold, plan not stated
35,000
$488.11K
12.1%
22 Mar 2007
Chairman of the Board
Sold, plan not stated
17,700
$216.47K
6.8%
8 Jan 2007
Chairman, Pres. & CEO
Sold, plan not stated
3,592
$52.12K
1.7%
52 decisions on file.